Correlation Between Centessa Pharmaceuticals and Replimune
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Replimune Group, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Replimune.
Diversification Opportunities for Centessa Pharmaceuticals and Replimune
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Centessa and Replimune is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Replimune go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Replimune
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to under-perform the Replimune. But the stock apears to be less risky and, when comparing its historical volatility, Centessa Pharmaceuticals PLC is 1.61 times less risky than Replimune. The stock trades about -0.03 of its potential returns per unit of risk. The Replimune Group is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 1,256 in Replimune Group on November 3, 2024 and sell it today you would earn a total of 142.00 from holding Replimune Group or generate 11.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Replimune Group
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Replimune Group |
Centessa Pharmaceuticals and Replimune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Replimune
The main advantage of trading using opposite Centessa Pharmaceuticals and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.The idea behind Centessa Pharmaceuticals PLC and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |